MedTrace Logo

Evaluate the Bioavailability Between 2 BMS-986141 Formulations in Healthy Participants

NCT03035734 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2018-03-23

No results posted yet for this study

Summary

Open label, randomized, 4-period crossover study with single doses of BMS-986141 given to healthy female subjects of non-childbearing potential and healthy males.

Conditions

  • Healthy

Interventions

DRUG

BMS-986141 Form A Tablet

tablet

DRUG

BMS-986141 Form B tablet (low dose)

tablet

DRUG

BMS-986141 Form B tablet (high dose)

tablet

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-25
Primary Completion
2017-02-07
Completion
2017-02-07

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03035734 on ClinicalTrials.gov